客製化抗体市场规模、份额及成长分析（按类型、服务、宿主动物、应用、最终用户和地区划分）－2025-2032年产业预测

预计到 2023 年，全球客製化抗体市场规模将达到 1.499 亿美元，到 2024 年将达到 1.6369 亿美元，到 2032 年将达到 3.3098 亿美元，预测期（2025-2032 年）的复合年增长率为 9.2%。

全球客製化抗体市场正经历显着成长，这主要得益于对个人化治疗和诊断需求的不断增长。精准医疗的兴起凸显了对能够区分密切相关异构体的特异性抗体试剂的需求。随着人类蛋白质体的逐步解析，新的研究标靶不断涌现，这需要能够检测细微结构差异的精密工具。此外，人们对抗体药物复合体（ADC）的兴趣日益浓厚，这为市场带来了更多机会，例如副ADC等创新方法有望带来超越传统化疗的治疗效果。 Enherz等产品的成功展现了强大的投资潜力，促使企业优化其抗体研发管线。因此，对定制发现和亲和性成熟计划的需求持续增长，确保了市场的持续扩张。

全球客製化抗体市场驱动因素

精准医疗需求的日益增长是全球客製化抗体市场的主要驱动力。这些客製化抗体能够精准标靶化特定疾病通路，并在自体免疫疾病、感染疾病和癌症相关疾病的研究中发挥关键作用。 Abcam 和 Thermo Fisher 等主要企业正在扩大其抗体研发投入，以增​​强生物製药公司的临床研发管线。这种向客製化抗体解决方案的转变体现在生物技术和製药业对这些项目的日益普及，进一步推动了市场成长和创新。这些趋势的融合凸显了客製化抗体在推动医疗保健解决方案发展中的重要性。

限制全球客製化抗体市场的因素

全球客製化抗体市场面临的主要挑战在于抗体生产和检测的高成本和漫长流程。学术机构和小型实验室资金和资源的匮乏阻碍了客製化抗体的广泛应用。因此，新参与企业常常反映，交货时间延长和生产成本上升限制了其自主研发的客製化抗体产品的扩充性。这种情况阻碍了定制抗体的更广泛应用，限制了该领域的创新和发展潜力，因为许多研究人员难以有效地将这些宝贵的工具应用于他们的研究中。

全球客製化抗体市场趋势

全球客製化抗体市场正经历一场重大变革，其驱动力来自自动化和人工智慧技术的进步。创新的人工智慧平台正在提高抗体发现的效率，优化开发精确度，同时降低相关成本。这一趋势的特点是利用先进的电脑建模技术设计抗体，以实现与目标蛋白的高亲和性结合。此外，分散式自动化解决方案的涌现，提高了各个治疗领域抗体筛检和合格流程的效率。这种技术与生物技术的融合正在推动客製化抗体生产的快速成长和效率提升，为市场未来的发展奠定了坚实的基础。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境

客製化抗体市场规模（按类型划分）及复合年增长率（2025-2032 年）

• 市场概览
• 单株抗体
• 多株抗体
• 重组抗体
• 其他客製化抗体形式

客製化抗体市场规模（按服务类型划分）及复合年增长率（2025-2032 年）

• 市场概览
• 抗体生成
• 抗体生产和纯化
• 碎片化和标籤服务

按宿主物种分類的客製化抗体市场规模及复合年增长率（2025-2032 年）

• 市场概览
• 老鼠
• 兔子
• 其他动物/替代宿主

客製化抗体市场规模（按应用领域划分）及复合年增长率（2025-2032 年）

• 市场概览
• 肿瘤学
• 感染疾病
• 神经生物学
• 干细胞研究
• 免疫学及其他

客製化抗体市场规模（按最终用户划分）及复合年增长率（2025-2032 年）

• 市场概览
• 製药和生物技术公司
• 学术和研究机构
• 受託研究机构（CRO）

客製化抗体市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2024 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2024 年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2022-2024年营收年比比较

主要企业简介

• Thermo Fisher Scientific Inc.
• Abcam plc
• Bio-Rad Laboratories, Inc.
• GenScript Biotech Corporation
• Creative Biolabs Inc.
• Rockland Immunochemicals Inc.
• Merck Group
• Cell Signaling Technology, Inc.
• BioLegend, Inc.
• Agilent Technologies, Inc.
• ProMab Biotechnologies
• Innovagen AB
• ProteoGenix
• Abnova Corporation
• Precision Antibody
• Sino Biological Inc.
• LifeSpan BioSciences, Inc.
• RayBiotech Inc.
• Rockland
• Labcorp Drug Development

结论与建议

Global Custom Antibody Market size was valued at USD 149.9 million in 2023 and is poised to grow from USD 163.69 million in 2024 to USD 330.98 million by 2032, growing at a CAGR of 9.2% during the forecast period (2025-2032).

The global custom antibody market is witnessing substantial growth driven by increasing demand for personalized therapeutic and diagnostic agents. The shift towards precision medicine emphasizes the need for specific antibody reagents capable of differentiating between closely related protein isoforms. As a significant portion of the human proteome nears completion, new research targets emerge, necessitating advanced tools that can detect minute structural differences. Additionally, the rising interest in antibody-drug conjugates (ADCs) presents further market opportunities, with innovative approaches, such as Deputy ADCs, enhancing therapeutic efficacy beyond traditional chemotherapy. The success of products like Enhertu demonstrates strong investment potential, compelling companies to refine their antibody pipelines. Consequently, the requirement for custom discovery and affinity-maturation projects continues to thrive, ensuring ongoing market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Custom Antibody market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Custom Antibody Market Segments Analysis

Global Custom Antibody Market is segmented by Type, Service, Host Animal, Application, End-User and region. Based on Type, the market is segmented into Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom-Antibody Formats. Based on Service, the market is segmented into Antibody Development, Antibody Production & Purification and Fragmentation & Labelling Services. Based on Host Animal, the market is segmented into Mice, Rabbits and Other Animals / Alternative Hosts. Based on Application, the market is segmented into Oncology, Infectious Diseases, Neurobiology, Stem Cell Research and Immunology & Others. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Contract Research Organisations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Custom Antibody Market

The growing demand for precision medicine significantly propels the global custom antibody market, as these tailored antibodies play a crucial role in researching autoimmune, infectious, and cancer-related diseases by enabling precise targeting of specific disease pathways. Prominent companies like Abcam and Thermo Fisher are expanding their antibody discovery efforts to enhance clinical pipelines for biopharmaceutical firms. This shift towards custom antibody solutions is reflected in the increased adoption of these programs across the biotech and pharmaceutical industries, further driving market growth and innovation. The convergence of these trends underscores the importance of custom antibodies in advancing healthcare solutions.

Restraints in the Global Custom Antibody Market

The Global Custom Antibody market encounters significant challenges primarily due to the high costs and lengthy timelines associated with antibody production and testing. Limited funding and resources at academic institutions and smaller laboratories hinder the widespread adoption of custom antibodies. As a result, new companies often report that slow turnaround times and elevated production expenses impede the scalability of their bespoke antibody offerings. This situation creates barriers for broader access and utilization, restricting the potential for innovation and progress in the field, as many researchers struggle to implement these valuable tools in their work effectively.

Market Trends of the Global Custom Antibody Market

The Global Custom Antibody market is experiencing significant transformation driven by advancements in automation and artificial intelligence. Innovative AI-enabled platforms are enhancing the efficiency of antibody discovery, optimizing accuracy and reducing costs associated with development. This trend is characterized by the engineering of antibodies using sophisticated computer modeling to achieve high affinity binding to target proteins. In addition, decentralized automation solutions are emerging, facilitating streamlined screening and qualification processes for antibodies across various therapeutic areas. This convergence of technology and biotechnology is fostering rapid growth and efficiency in custom antibody production, positioning the market for promising future developments.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Custom Antibody Market Size by Type & CAGR (2025-2032)

• Market Overview
• Monoclonal Antibodies
• Polyclonal Antibodies
• Recombinant Antibodies
• Other Custom-Antibody Formats

Global Custom Antibody Market Size by Service & CAGR (2025-2032)

• Market Overview
• Antibody Development
• Antibody Production & Purification
• Fragmentation & Labelling Services

Global Custom Antibody Market Size by Host Animal & CAGR (2025-2032)

• Market Overview
• Mice
• Rabbits
• Other Animals / Alternative Hosts

Global Custom Antibody Market Size by Application & CAGR (2025-2032)

• Market Overview
• Oncology
• Infectious Diseases
• Neurobiology
• Stem Cell Research
• Immunology & Others

Global Custom Antibody Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organisations (CROs)

Global Custom Antibody Market Size & CAGR (2025-2032)

• North America (Type, Service, Host Animal, Application, End-User)
  • US
  • Canada
• Europe (Type, Service, Host Animal, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Service, Host Animal, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Service, Host Animal, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Service, Host Animal, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biolabs Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rockland Immunochemicals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLegend, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ProMab Biotechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Innovagen AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ProteoGenix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abnova Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision Antibody
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Biological Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeSpan BioSciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RayBiotech Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rockland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcorp Drug Development
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations